Revenue
-
Net Income
-$247.3M
▼ 14.6% YoY
EPS
$-3.07
▲ 5.2% YoY
Cash
$111.1M
▲ 49.2% YoY
FY 2025 · As of 2025-03-31
Last 90 days
| Insider | Type | Date | Shares | Price | Value | |
|---|---|---|---|---|---|---|
Sarchi Christopher Chief Commercial Officer | Sell | Jun 1, 2026 | 12.0K | $9.24 | $111K | Form 4 ↗ |
Xynos Konstantinos Chief Medical Officer | Sell | May 18, 2026 | 14.0K | $5.08 | $71K | Form 4 ↗ |
Schwendenman Andrew Chief Accounting Officer | Sell | May 18, 2026 | 7.9K | $5.08 | $40K | Form 4 ↗ |
Sarchi Christopher Chief Commercial Officer | Sell | May 18, 2026 | 8.6K | $5.08 | $44K | Form 4 ↗ |
Astley-Sparke Philip | Sell | May 18, 2026 | 17.7K | $5.08 | $90K | Form 4 ↗ |
Patel Sushil Chief Executive Officer | Sell | May 18, 2026 | 37.3K | $5.08 | $190K | Form 4 ↗ |
Hill Emily Luisa Chief Financial Officer | Sell | May 18, 2026 | 7.8K | $5.08 | $40K | Form 4 ↗ |
Sarchi Christopher Chief Commercial Officer | Grant | Apr 1, 2026 | 50.0K | $0.00 | $0 | Form 4 ↗ |
Astley-Sparke Philip | Grant | Apr 1, 2026 | 50.0K | $0.00 | $0 | Form 4 ↗ |
Xynos Konstantinos Chief Medical Officer | Grant | Apr 1, 2026 | 50.0K | $0.00 | $0 | Form 4 ↗ |